André Michael Eckardt

Prof. Dr. André Michael Eckardt

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2005 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
JBJosé Baselga
José Baselga
JTJosé M. Trigo
José M. Trigo
Jean BourhisJean Bourhis
Jean Bourhis
JTJacques Tortochaux
Jacques Tortochaux
HCHernán Cortés-Funes
Hernán Cortés-Funes
AEAndré Michael Eckardt
André Michael Eckardt
Purpose: To evaluate the efficacy and safety of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients and Methods: Ninety-six eligible patients received cetuximab (initial dose of 400 mg/m2 followed by subsequent weekly doses of 250 mg/m2) followed by platinum chemotherapy at the same dose and schedule at which progressive disease was documented before entry onto the study. Results: The response rate, based on an independently read assessment, in the intent-to-treat population was 10%, with a disease control rate (complete response, partial response [PR], and stable disease) of 53%. The median time to progression and overall survival were 85 and 183 days, respectively; both were longest in patients achieving a PR (median, 203.5 and 294 days, respectively). Treatment was well tolerated. The most common cetuximab-related adverse events were skin reactions, particularly an acne-like rash. Conclusion: The combination of cetuximab and platinum chemotherapy is an active and well-tolerated approach to the treatment of this poor-prognosis patient population with platinum-refractory recurrent or metastatic SCCHN for whom there are no recommended standard therapeutic options.

1 August 2003 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
AEAndré Michael Eckardt
André Michael Eckardt
KFKonstantinos Fokas
Konstantinos Fokas

1 February 2007 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
MKMatthias Karst
Matthias Karst
MWMichael Winterhalter
Michael Winterhalter
SMSinikka Münte
Sinikka Münte
BFBoris Francki
Boris Francki
AHApostolos Hondronikos
Apostolos Hondronikos
MFMatthias Fink
Matthias Fink
Auricular acupuncture can be an effective treatment for acute anxiety, but there is a lack of direct comparisons of acupuncture to proven standard drug treatments. In this study we compared the efficacy of auricular acupuncture with intranasal midazolam, placebo acupuncture, and no treatment for reducing dental anxiety. Patients having dental extractions (n = 67) were randomized to (i) auricular acupuncture, (ii) placebo acupuncture, and (iii) intranasal midazolam and compared with a no treatment group. Anxiety was assessed before the interventions, at 30 min, and after the dental extraction. Physiological variables were assessed continuously. With the no treatment group as control, the auricular acupuncture group, and the midazolam group were significantly less anxious at 30 min as compared with patients in the placebo acupuncture group (Spielberger Stait-Trait Anxiety Inventory X1, P = 0.012 and <0.001, respectively). In addition, patient compliance assessed by the dentist was significantly improved if auricular acupuncture or application of intranasal midazolam had been performed (P = 0.032 and 0.049, respectively). In conclusion, both, auricular acupuncture and intranasal midazolam were similarly effective for the treatment of dental anxiety.

18 March 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
AEAndré Michael Eckardt
André Michael Eckardt
Juliana LemoundJuliana Lemound
Juliana Lemound
Majeed RanaMajeed Rana
Majeed Rana
NGNils-Claudius Bernhard Gellrich
Nils-Claudius Bernhard Gellrich
Lymphomas of the orbit and orbital adnexae are rare tumors, comprising only 1% of all non-Hodgkin’s lymphoma. The majority of non-Hodgkin’s lymphomas of the orbit are extranodal marginal-zone B-cell lymphomas of mucosa-associated lymphoid tissue type. Because of nonspecific clinical signs and symptoms, some diagnostic delay may occur. The purpose of the study was to evaluate the diagnostic approach in orbital lymphomas and to analyze their treatment outcome.

7 April 2014 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MAMoran Amit
Moran Amit
YBYoav Binenbaum
Yoav Binenbaum
LTLeonor Trejo–Leider
Leonor Trejo–Leider
KSKanika Sharma
Kanika Sharma
NRNaomi Ramer
Naomi Ramer
Ziv GilZiv Gil
Ziv Gil

1 November 2005 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
AEAndré Michael Eckardt
André Michael Eckardt
GSGwen R. J Swennen
Gwen R. J Swennen
Functional mandibular reconstruction after tumor resection is challenging. Currently, voxel-based craniofacial surgery and virtual planning of craniofacial surgical procedures are becoming increasingly popular. We report on a 56-year-old patient with an infiltrating recurrent squamous cell carcinoma of the mandible and buccal mucosa. Virtual resection of the mandible was accomplished using virtual reality techniques. Based on virtual geometric data, a metal template was configured for optimal contouration of a fibular bone graft while it was still pedicled in the donor field. Our operative procedure demonstrates the usefulness of voxel-based three-dimensional cephalometry in virtual planning of microsurgical bone transfer for mandibular reconstruction.